During the past decade, Uniklinik RWTH Aachen; Klinik IV; Klinik Hämatologie, Onkologie, Hämostaseologie und Stamm. conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Uniklinik RWTH Aachen; Klinik IV; Klinik Hämatologie, Onkologie, Hämostaseologie und Stamm." #1 collaborator was "AbbVie" with 1 trials as a collaborator, "German CLL Study Group" with 1 trials as a collaborator, "Ludwig-Maximilians - University of Munich" with 1 trials as a collaborator, "Novartis Pharmaceuticals" with 1 trials as a collaborator and "PharmaEssentia (Co-Sponsor for USA)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Uniklinik RWTH Aachen; Klinik IV; Klinik Hämatologie, Onkologie, Hämostaseologie und Stamm." are "Chronic Myeloid Leukemia" (2 trials), "Polycythemia Vera" (2 trials), "Leukemia, Myeloid, Acute" (1 trials), "Lymphocytic Leukemia, Chronic" (1 trials) and "Paroxysmal Hemoglobinuria, Nocturnal" (1 trials). Many other conditions were trialed in "Uniklinik RWTH Aachen; Klinik IV; Klinik Hämatologie, Onkologie, Hämostaseologie und Stamm." in a lesser frequency.

Most popular intervention types in "Uniklinik RWTH Aachen; Klinik IV; Klinik Hämatologie, Onkologie, Hämostaseologie und Stamm." are "Drug" (7 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Asciminib" (1 trials), "Best available therapy (BAT)" (1 trials), "Chlorambucil" (1 trials) and "Crovalimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Uniklinik RWTH Aachen; Klinik IV; Klinik Hämatologie, Onkologie, Hämostaseologie und Stamm." are 7 trials for "All" genders.

Currently, there are NaN active trials in "Uniklinik RWTH Aachen; Klinik IV; Klinik Hämatologie, Onkologie, Hämostaseologie und Stamm.". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Uniklinik RWTH Aachen; Klinik IV; Klinik Hämatologie, Onkologie, Hämostaseologie und Stamm., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Uniklinik RWTH Aachen; Klinik IV; Klinik Hämatologie, Onkologie, Hämostaseologie und Stamm., 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".